NYSE:EVRCapital Markets
Is Evercore’s Biotech Banking Push Quietly Redefining Its Core Strategy for EVR?
Earlier in March, Evercore announced the hire of David Ke as a senior managing director in its equity capital markets group focused on biotechnology, and the firm recently participated in the 2026 Life Science Intelligence Summit through a healthcare investment banking presentation by Bennett Blau.
These developments highlight Evercore’s growing emphasis on healthcare and biotechnology advisory and capital-raising capabilities, reinforcing its presence in life sciences investment...